$KETA shares to rally strong, imo TripSitter Clinic Ltd. $KETA/$KETA.C is looking to capitalize on the growing mental health services industry, psychedelics industry, and telemedicine industry all in one.
With mental healthcare seeing a large push into the online space, $KETA’s goal is to simplify the use of ketamine-based therapies to treat common mental health problems via a SaaS-based platform that connects mental health professionals directly with patients.
$KETA’s decades of combined experience in the greater ketamine industry drive their treatment protocols. Due to its excellent safety record, ketamine has been a marvel of the medical world, studied extensively, and proven as a powerful therapeutic in providing both immediate and sustained relief to patients. $KETA’s breadth of experience in this field stands to make them a major player in the field IMO.
Shares of $KETA have seen a steep decline since IPO, but I’m expecting shares to rally strong once the psychedelics industry as a whole begins to see a revival. Once treatments are more widely accepted and more trials prove the efficacy of psychedelic treatments, I expect to see companies like $KETA flourish.
Shares of $KETA are currently trading at $.31 and the company is valued at $9.37 million.
https://assets.website-files.com/612dbca13b24df5fda6c48e5/61a67a6faa4269231b3bec78_TripSitter-Clinic-Company-Deck.pdf